<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for KYTH</title>
    <link />
    <description>Headlines for Kythera Biopharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Bearish MACD for Kythera Biopharmaceuticals Inc. - Tale of the Tape</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97794/bearish-macd-for-kythera-biopharmaceuticals-inc.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 24 Apr 2013 11:48:01 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals Presents Positive MRI Results from Phase IIb Study of ATX-101 in Reductio</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/04/3494983/kythera-biopharmaceuticals-presents-positive-mri-results-from-phase-iib-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Sat, 13 Apr 2013 21:18:38 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals, Inc. Presents Positive Magnetic Resonance Imaging (MRI) Results from Pha</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/13/kythera-biopharmaceuticals-inc-presents-positive-m/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 13 Apr 2013 17:05:13 GMT</pubDate>
    </item>
    <item>
      <title>Data Presented on Bayer's ATX-101 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96546/data-presented-on-bayers-atx-101.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 17:30:01 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals Announces Positive Interim Phase IIIb Results from Open-Label Study of AT</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3476376/kythera-biopharmaceuticals-announces-positive-interim-phase-iiib-results-from-ope.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Sat, 06 Apr 2013 10:52:01 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/06/kythera-biopharmaceuticals-inc-announces-positive-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 06 Apr 2013 10:50:14 GMT</pubDate>
    </item>
    <item>
      <title>Is Kythera's Double Chin Drug A Winner?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1316231-is-kythera-s-double-chin-drug-a-winner.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 02 Apr 2013 19:57:27 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals Announces 2012 Operating Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/21/kythera-biopharmaceuticals-announces-2012-operatin/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Mar 2013 16:34:46 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Hits 52-Week High - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94644/gilead-hits-52-week-high.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 13 Mar 2013 09:50:01 GMT</pubDate>
    </item>
    <item>
      <title>CBST Gets Global Rights to Antibiotic Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94605/cbst-gets-global-rights-to-antibiotic-candidate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 12 Mar 2013 17:52:01 GMT</pubDate>
    </item>
    <item>
      <title>Medical Aesthetics Veteran Frederick Beddingfield, III, MD, PhD Appointed New Chief Medical Officer</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/12/medical-aesthetics-veteran-frederick-beddingfield-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 12 Mar 2013 17:20:34 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging Data Presented by Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94558/encouraging-data-presented-by-gilead.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 12 Mar 2013 13:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Gilead's HIV Pipeline - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94254/good-news-for-gileads-hiv-pipeline.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 07 Mar 2013 13:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Kythera Biopharmaceuticals' CEO Presents at Cowen Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1248981-kythera-biopharmaceuticals-ceo-presents-at-cowen-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 17:04:01 GMT</pubDate>
    </item>
    <item>
      <title>Celgene's Apremilast Encourages - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93919/celgenes-apremilast-encourages.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 04 Mar 2013 13:30:01 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of 'Double</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3383849/kythera-announces-positive-interim-results-from-open-label-study-of-atx-101-in-re.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Sat, 02 Mar 2013 10:46:30 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/02/kythera-biopharmaceuticals-inc-announces-positive-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 02 Mar 2013 09:20:18 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals, Inc. to Present New Data at 2013 American Academy of Dermatology (AAD) A</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/01/kythera-biopharmaceuticals-inc-to-present-new-data/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 01 Mar 2013 16:35:35 GMT</pubDate>
    </item>
    <item>
      <title>Medivation Beats 4Q Expectations - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93771/medivation-beats-4q-expectations.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 01 Mar 2013 09:00:01 GMT</pubDate>
    </item>
    <item>
      <title>KYTHERA Biopharmaceuticals to Present at Cowen and Company 33rd Annual Health Care Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/26/kythera-biopharmaceuticals-to-present-at-cowen-and/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Feb 2013 20:20:13 GMT</pubDate>
    </item>
  </channel>
</rss>
